Global Parkinson’s Disease Drugs Market Forecasts to 2024

1. Parkinson’s Disease Drugs Market

2. Global Parkinson’s Disease Drugs Market Forecasts to 2024 Global Contact Lenses Market Drivers, Opportunities, Trends, & Forecasts 2018 - 2024 https://www.infoholicresearch.com/report/parkinsons-disease-drugs-market-forecasts-2024/

3. Report Overview Parkinson’s disease is one of the most prevalent neurodegenerative disorders, which progresses with age because of damaged dopaminergic cells in the brain. Bradykinesia, rigidity, postural instability, and tremors are the symptoms of the Parkinson’s disease. Huge patient pool and rising rate of diagnosis are the significant factors driving the market growth. The Parkinson’s Disease Foundation has stated that nearly 10 million people are suffering from this disorder globally. The highest frequency of this disorder is observed in developed countries, and in the US, almost 60,000 new cases are reported annually. PD is an idiopathic disease for which the cause of the occurrence is still unknown, hence only symptomatic drugs are available in the market for the treatment. Furthermore, the disorder is diagnosed in the final stages when the majority of the cells that produce dopamine lose their functionality. This is demanding more innovative and novel drugs for the treatment. Buy Complete Report: https://www.infoholicresearch.com/report/parkinsons-disease-drugs-market-forecasts-2024/

4. Key Players The major players in the market include Novartis, Roche, AbbVie, Teva Pharmaceutical, Pfizer, STADA Arzneimittel AG, GSK, Valeant, Merck & Co. Inc., and Amneal Pharmaceuticals Inc. Market Analysis: ` The “Global Parkinson’s Disease Drugs Market” is estimated to witness a CAGR of 7.2% during the forecast period 2018–2024. The market is analyzed based on two segments – drug class and regions. 110 Pages|17 Tables |50 Charts |4 Regions |13 Companies | 10 Enquiry Hours Get Sample Report https://www.infoholicresearch.com/request-a-sample-report/?repid=10918

5. 10% Free Customization On This Report • https://www.infoholicresearch.com/request-a-sample-report/?repid=10918 • https://www.infoholicresearch.com/engage-with-analyst/?repid=10918 • https://www.infoholicresearch.com/customize-sample/?repid=10918 • https://www.infoholicresearch.com/enquiry-before-buying/?repid=10918

6. Competitive Analysis New product launch and collaboration are the primary strategies being followed by the market players to maintain their leadership and strengthen the market position. In January 2015, Neuropore Therapies Inc. and UCB S.A. signed a commercialization agreement for NPT200-11. Recently, Impax Pharmaceuticals’ RYTARY and AbbVie’s DUOPA received the US FDA approval for the treatment of Parkinson’s disease. Other strategies include business partnerships, mergers & acquisitions, and a multifaceted pipeline. Recently, in January 2018, Adamas Pharmaceuticals Inc. launched Gocovri for the treatment of dyskinesia in individuals with PD, who are taking levodopa. Regional Analysis The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America accounts for the largest share of the market, followed by Europe, Asia Pacific, and Rest of the World. More than 40% of the market is occupied by Europe, with Germany being the major contributor to the market growth.

7. Methodology Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps: Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services. Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

8. About Infoholic Research Infoholic Research(https://www.infoholicresearch.com/)is a global market research and consulting organization providing strategic and high-level market intelligence in emerging and niche markets in Healthcare, ICT, Semiconductors, Chemicals & Materials domain. We aim at delivering high-quality results to our clients providing them with in-depth industry insights to identify new business opportunities and nurture their business strategies. Our team of analysts spanning verticals such as ICT, Healthcare, Chemicals and Semiconductors creates extensive Market Research reports every month covering market trends and dynamics envisioning the road ahead. We also have a Newsletter wherein we keep on featuring guest columns from domain experts, tête-à-tête with leaders and likewise. Additionally, our insightful blogs and articles truly keep the readers hooked. You may also send in your requests for getting our analysts’ viewpoints in specific areas of Healthcare, ICT, Chemicals & Materials, and Semiconductors to validate a certain market trend/ insight or finding. Please let me know how we both can create a cohesive quotient and associate for creating a win-win situation for both of us. https://www.infoholicresearch.com/report/parkinsons-disease-drugs-market-forecasts-2024/

9. Contact Us Infoholic Research45/1, Residency Road Cross,5th Floor, Leo Shopping Complex, Bengaluru – 560025, IndiaEmail: sales@infoholicresearch.com Linkedin: https://www.linkedin.com/company/infoholic-research/ https://www.infoholicresearch.com/report/parkinsons-disease-drugs-market-forecasts-2024/